Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Neoplasms × Brachytherapy × Clear all

Status

Sponsor Class

OTHER 6 INDUSTRY 3 NIH 1 NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Uterine Cervical Neoplasms 13 Prostatic Neoplasms 5 Sarcoma 4 Breast Neoplasms 4 Radiation Injuries 2 Carcinoma, Ductal, Breast 2 Obesity 1 Neurotoxicity Syndromes 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms 1 Fatigue 1 Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation 1 Endometrial Clear Cell Adenocarcinoma 1 Drug-Related Side Effects and Adverse Reactions 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Carcinoma In Situ 1 Anemia 1

Interventions

fludarabine phosphate 2 fludarabine 2 Whole-Body Irradiation 2 Tacrolimus 2 Surveys and Questionnaires 2 Proton Therapy 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Cyclophosphamide 2 Busulfan 2 tremelimumab 1 motesanib diphosphate 1 luprolide acetate gel depot 1 liposomal amphotericin B 1 durvalumab 1 copanlisib 1 chlorhexidine gluconate 1 batifiban 1 Whole Genome Sequencing 1 Watchful Waiting 1 Thrombopoietin 1 Taxes 1 Spermine Synthase 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Psychiatrists 1 Psilocybin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01255748 2025-09-09

Registry Study for Radiation Therapy Outcomes

Proton Collaborative Group

40,000 enrolled

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡